# A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer

> **NCT05385809** · — · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Unresectable Gastric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05385809
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2022-07-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05385809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05385809, "A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05385809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
